Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000007

Chief Executive Officer sold 1,127 shares at $9.27 ($10,447)

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-18 Sale : show line 1 in the form −1,127 $9.27 $10,447 240,991 D
Open-market sales · 1,127 sh · avg $9.27 · $10,447
Loading xslF345X05/form4-11202025_101125.xml…